Multifactorial Complex Diseases > Hero Banner > Dassault Systèmes

Multifactorial Complex Diseases

The rise of chronic diseases and number of patients with unmet medical needs as a result of an ageing population, lifestyle changes & urbanization has catalyzed the Life Sciences industry into action.

Rising to the Challenge

Read our eBook to discover how to develop more innovative, personalized, sustainable products that improve upon patient outcomes.

Discover our articles

FACE NEW CHALLENGES

Innovate Towards Precision Health

Precision medicine promises to revolutionize healthcare, with its key goal of providing the right treatment to the right patient at the right time and dose, and thus the potential of improving quality of life and helping to bring down healthcare costs.

 

Recent scientific breakthroughs and technological advancements have improved our disease knowledge and altered diagnosis and treatment approaches resulting in more precise, predictive, preventative and personalized healthcare that is customized for the individual patient. In addition, the big data revolution has provided an opportunity for Life Sciences companies to apply artificial intelligence and machine learning algorithms to mine vast data sets and virtual twin experiences enable companies to bridge the gap between the experimental and real worlds and enhance disease understanding.

 

Leveraging recent scientific breakthroughs and technological advancements to improve our understanding of disease pathogenesis and change the way we diagnose and treat the disease can help Life Sciences companies create more precise, predictable, and powerful personalized solutions.

 

The application of technology advancements to drive competitive advantage allows Life Sciences companies to:

Enhanced Portfolio > Dassault Systèmes

Anticipate & reduce risk with enhanced portfolio management

Number of indications >Dassault Systèmes

Increase number of indications for existing products

Improved Quality > Dassault Systèmes

Improved quality & efficacy

Collaboration > Dassault Systèmes

Increased collaboration

Machine learning reveals novel patient subtypes for rare disease

Castleman Disease Collaborative Network and MEDIDATA advance potential diagnosis and treatment options with omics data.

ADOPT THE STRATEGY

Accelerated Collaborative & Scientific Innovation - closing the loop between the real and the virtual to optimize therapeutic efficacy and safety

Life Sciences companies worldwide are under increasing pressure to improve the patient experience and outcome by accelerating the delivery of innovative therapies and solutions meeting previously unmet medical needs of the highest quality and efficacy.

 

The 3DEXPERIENCE® platform enables Life Sciences companies to create experiences to satisfy unmet medical needs and improve patient outcomes in global markets in one virtual environment (exploration, discovery, development, testing, commercialization) – with full visibility across their internal and external ecosystems.

 

With the 3DEXPERIENCE platform, Life Sciences companies can effectively develop and manage laboratory processes and specifications with a multi-disciplinary scientific modeling and simulation approach. The platform allows closing the loop between the real and the virtual world, consolidating real data from the bench, and empowering stakeholders with virtual simulations significantly reducing time to market – allowing patient access to the right treatment at the right time.

IASO - Transforming the Patient Experience

Named after the Greek goddess of recovery, IASO is a Dassault Systèmes showcase for the lifecycle of a combination product in oncology.  From upstream thinking through commercialization, IASO demonstrates the value that Dassault Systèmes and the 3DEXPERIENCE can deliver to stakeholders challenged with bringing innovation to market in the form of combination products and transforming the patient experience.

Transforming patient relationships

Otto Bock HealthCare GmbH implemented the 3DEXPERIENCE® platform and precisely modeled its advanced prosthetic hand – the Michelangelo - within a very short timeframe.

The 3DEXPERIENCE® platform along with CATIA Imagine and Shape provided Otto Bock the ability to design their prothese to be as natural as possible.

Michael Kornfeind
Michael Kornfeind
Head of Mechanical R&D 2 Otto Bock Healthcare Products GmbH

Explore our Industry Solution Experiences

Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.

More Life Sciences & Healthcare Challenges